BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: iTeos Therapeutics, Inc. (Nasdaq - ITOS), ZimVie Inc. (Nasdaq - ZIMV), PharmChem, Inc. (OTC - PCHM), NV5 Global, Inc. (Nasdaq - NVEE)
Written by Emily J. Thompson, Senior Investment Analyst
Source: Globenewswire
Investigation Announcements: Brodsky & Smith is investigating potential breaches of fiduciary duties by the boards of iTeos Therapeutics, ZimVie, PharmChem, and NV5 Global in relation to their respective acquisition deals, questioning whether shareholders are receiving fair value.
Contact Information: Investors who own shares in these companies and wish to discuss the investigations can contact attorneys Jason Brodsky or Marc Ackerman at Brodsky & Smith without any financial obligation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
